Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11:19 | Deutsche Bank raises Trustpilot stock price target to GBP3.43 on strong earnings | ||
11:18 | Vitol and Glencore set to bid for Chevron's Singapore refinery stake - report | ||
11:18 | Eli Lilly cautious on using FDA's new fast-track review for weight-loss pill | ||
11:18 | Chinese automaker Chery plans $1.2 billion Hong Kong IPO | ||
11:18 | Flat Capital to acquire Double Sunday in share exchange deal | ||
11:18 | Verisure plans $3.7 billion IPO on Nasdaq Stockholm | ||
11:18 | Incyte's povorcitinib shows strong results in hidradenitis suppurativa trial | ||
11:18 | Structure Therapeutics stock rating reiterated by JMP, citing positive safety data | ||
11:18 | Kura Oncology stock rating reiterated at Market Outperform by Citizens JMP | ||
11:18 | Citizens JMP reiterates Market Outperform rating on Mirum Pharmaceuticals stock | ||
11:18 | DraftKings stock rating reiterated at Market Outperform by Citizens JMP | ||
11:18 | Duolingo stock rating reiterated at Market Outperform by JMP | ||
11:18 | Gaming and Leisure stock rating reiterated at Market Outperform by JMP | ||
11:18 | Citizens analyst reiterates Market Outperform rating on Acrivon stock | ||
11:18 | Goldman Sachs initiates coverage on Entrada Therapeutics stock with Early-Stage Biotech rating | ||
11:18 | Deutsche Bank raises Schaeffler stock price target to EUR4.70 on E-Mobility growth | ||
10:54 | Adtran Holdings prices $175 million convertible notes offering | ||
10:54 | Via Transportation awarded 10% royalty on RideCo's 'infringing' sales | ||
10:54 | Duolingo faces Hungarian probe over misleading claims, marketing tactics | ||
10:54 | China Unicom's Sanjiangyuan data center to deploy domestic AI chips | ||
10:54 | China iPhone sales decline for Apple before new release | ||
10:54 | South32 to hold annual general meeting on October 23 | ||
10:54 | Old Mutual sets interim dividend of 37 cents per share | ||
10:54 | Vodafone completes €806.5 million tender offer for euro securities | ||
10:54 | Morgan Stanley upgrades Centrica stock rating to Overweight on earnings potential |